Kelly Timothy P
Transaction: 02/25/2026
SELL
Change
-6,228
Price
$1.93
Filing
02/27/2026
Type
SELL
Caribou Biosciences, Inc.
CRBU • Biotechnology
$0.52
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$52.41M
Growth
-8.9%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.22Healthy liquidity · 5.71Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:21 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.52
Change0.00%
Shares Out100.99M
Market Cap$52.41M
Enterprise Value$-33.25M
52W Range1.38 - 3.54
Beta2.28
P/E-0.51
P/S6.14
P/B0.53
P/FCF-0.55
EV/Sales-3.89
Price$0.52
Change0.00%
Shares Out100.99M
Market Cap$52.41M
Enterprise Value$-33.25M
52W Range1.38 - 3.54
Beta2.28
P/E-0.51
P/S6.14
P/B0.53
P/FCF-0.55
EV/Sales-3.89
EV/EBITDA0.31
EV/FCF0.35
Earnings Yield-197.29%
FCF Yield-182.69%
Dividend Yield0.00%
Gross Margin67.34%
Oper. Margin-12.20%
Profit Margin-13.27%
Debt/Eq0.22
Current Ratio5.71
Quick Ratio5.71
Revenue 5Y-8.92%
Target$1.00
Target Upside92.68%
Target Median$1.00
Target Range1.00 - 1.00
Volume1.09M
Avg Volume1.81M
EPS Surprise0.07
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Manageable debt level · 0.22Healthy liquidity · 5.71Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-10-21
80/100
Bullish
Bullish
6
Hold
4
Bearish
0
Price Target
2026-08-14
Low
$3.00
Mean
$5.00
Median
$5.00
High
$7.00
Insider Transactions
Recent executive and insider activity
Albertson Tina M.
Transaction: 02/24/2026
SELL
Change
-1,066
Price
$1.96
Filing
02/24/2026
Type
SELL
Khan Ruhi Ahmad
Transaction: 02/24/2026
SELL
Change
-6,938
Price
$1.96
Filing
02/24/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kelly Timothy P | SELL | -6,228 | $1.93 | 02/25/2026 | 02/27/2026 |
| Albertson Tina M. | SELL | -1,066 | $1.96 | 02/24/2026 | 02/24/2026 |
| Khan Ruhi Ahmad | SELL | -6,938 | $1.96 | 02/24/2026 | 02/24/2026 |
| MCCLUNG BARBARA G | SELL | -6,938 | $1.96 | 02/24/2026 | 02/24/2026 |
| Kelly Timothy P | SELL | -3,147 | $1.96 | 02/24/2026 | 02/24/2026 |
| Albertson Tina M. | BUY | +55,000 | Not reported | 02/20/2026 | 02/24/2026 |
| Albertson Tina M. | BUY | +247,500 | $1.80 | 02/20/2026 | 02/24/2026 |
| Khan Ruhi Ahmad | BUY | +45,000 | Not reported | 02/20/2026 | 02/24/2026 |
| Khan Ruhi Ahmad | BUY | +202,500 | $1.80 | 02/20/2026 | 02/24/2026 |
| MCCLUNG BARBARA G | BUY | +202,500 | $1.80 | 02/20/2026 | 02/24/2026 |
| MCCLUNG BARBARA G | BUY | +45,000 | Not reported | 02/20/2026 | 02/24/2026 |
| Kelly Timothy P | BUY | +45,000 | Not reported | 02/20/2026 | 02/24/2026 |
| Kelly Timothy P | BUY | +202,500 | $1.80 | 02/20/2026 | 02/24/2026 |
| Haurwitz Rachel E. | BUY | +151,700 | Not reported | 02/20/2026 | 02/20/2026 |
| Haurwitz Rachel E. | BUY | +682,500 | $1.80 | 02/20/2026 | 02/20/2026 |
| Ryali Sriram | BUY | +55,000 | Not reported | 02/20/2026 | 02/20/2026 |
| Ryali Sriram | BUY | +247,500 | $1.80 | 02/20/2026 | 02/20/2026 |
| Braunstein Scott | BUY | +45,000 | $1.80 | 02/20/2026 | 02/20/2026 |
| GUGGENHIME ANDREW | BUY | +45,000 | $1.80 | 02/20/2026 | 02/20/2026 |
| JOHNSON DAVID LEE | BUY | +45,000 | $1.80 | 02/20/2026 | 02/20/2026 |